Primary Record
Regadenoson
- In stock
- 2,192 g
- Purity
- 99.4 %
- CAS
- 313348-27-5
Compound Identifiers & Properties
- CAS
- 313348-27-5
- PubChem CID
- 219024
- SMILES
- CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N
- Canonical SMILES
- CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1
Names & Synonyms
- Regadenoson
- Lexiscan
- Rapiscan
- 313348-27-5
- Regadenoson anhydrous
- regadenosonum
- Lexiscan (TN)
- Regadenoson (INN)
- CVT-3146
- Regadenoson monohydrate
- Regadenoson (Standard)
- Regadenoson [USAN:INN]
- Regadenoson Impurity 18
- REGADENOSON [MI]
- RefChem:426699
- 7AXV542LZ4
- REGADENOSON [INN]
- UNII-7AXV542LZ4
- DTXSID4057712
- D0XE1C
- Regadenoson; CVT-3146
- CVT 3146
- AC1Q5LB1
- CHEMBL317052
- REGADENOSON [MART.]
- DTXCID5031501
- SCHEMBL678893
- 2XLN4Y044H
- AC1L55X1
- C15H18N8O5
- GTPL5596
- orb1305186
- SCHEMBL29462353
- CTK4G6871
- HY-A0168R
- AOB6869
- C01EB21
- CVT3146
- CHEBI:135613
- LEXISCAN(R) (REGADENOSON)
- LZPZPHGJDAGEJZ-AKAIJSEGSA-N
- MFCD09832544
- GLXC-05958
- HMS3886O21
- AMY27715
- EX-A2148
- HY-A0168
- Tox21_113668
- AR-1D6945
- BDBM50119132
- CID219024
- EBC-26913
- s5358
- ZINC13818943
- AKOS026750593
- C15-H18-N8-O5
- AN-1022
- CCG-268525
- CS-5612
- CV-3146
- DB06213
- NR07283
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine
- NCGC00249892-01
- AC-35838
- AS-56292
- AT-36942
- BP-58629
- 2-[4-(methylcarbamoyl)-1h-pyrazol-1-yl]adenosine
- LS-193008
- B5904
- CAS-313348-27-5
- CVT-3146;CVT3146;CVT 3146
- J1.806.399I
- D12568
- 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
- Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
- 348R275
- A848906
- EN300-19633972
- 2-[4-(Methylcarbamoyl)-1H-pyrazole-1-yl]adenosine
- Q7307897
- Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-
- 2-[4-(Methylaminocarbonyl)-1H-pyrazole-1-yl]adenosine
- N-Methyl-1-(adenosine-2-yl)-1H-pyrazole-4-carboxamide
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine
- Adenosine,2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
- B0084-107114
- (1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide
- 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide
- 1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide
- 1-(6-Amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
- 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CVT 3146; Lexiscan; Regadenoson
- (1-{9-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-methylcarboxamide
- 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
- 1-[6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid methylamide
- 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide<br/>CVT 3146<br/>CVT-3146<br/>CVT3146<br/>Lexiscan<br/>regadenoson
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CV 3146; CVT 3146; Lexiscan; NQZ-021; Rapiscan; 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
- 36186-55-7
- 6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside;1-(6-amino-9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yloxy)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide